Nonresident fellow Hagop Kantarjian, chair of the Department of Leukemia at the MD Anderson Cancer, co-authors an article on countering pharmaceutical industry efforts to delay the release of affordable generic drugs in the United States.
Read his paper in Blood, a weekly medical journal published by the American Society of Hematology.
Aug. 26, 2016, 1:13 p.m.
Kirstin R.W. Matthews, Ph.D., is a fellow in science and technology policy at the Baker Institute. She is ...
Quianta Moore, M.D., is a Baker Institute Scholar in Health Policy. Her research focuses on developing empirically informed ...